Kevin R Lynch

10PUBLICATIONS
33CO-AUTHORS
Molecular medicineBiologically active moleculesClinical pharmacology and therapeuticsGene and molecular therapyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 02, 2025
Assessment of Spinster homologue 2 (Spns2)-dependent transport of sphingosine-1-phosphate as a therapeutic target.

Yugesh Kharel, Tao Huang, Kyle Dunnavant

|Jul 02, 2024
Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors.

Daniel J Foster, Kyle Dunnavant, Christopher W Shrader

|May 15, 2024
Assessing Spns2-dependent S1P Transport as a Prospective Therapeutic Target.

Y Kharel, T Huang, K Dunnavant

|Nov 09, 2023
Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects.

Gregory W Busey, Mohan C Manjegowda, Tao Huang

|Apr 03, 2023
2-Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2).

Ariel L Burgio, Christopher W Shrader, Yugesh Kharel

|Oct 25, 2022
Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues.

Srinath Pashikanti, Daniel J Foster, Yugesh Kharel

Pageof 2